In this regard, activin-A has been shown to induce deviation of immune response towards a type 2 phenotype [49], and Peg-INF-α eradicates the viral infection by altering the immune response in patients with CHC from Th2 to a Th1 mediated pattern [8]. The gene discussed is IFNA17; the disease is viral infectious disease.